These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 25228560)
1. Thalassemia major and sickle cell disease in adolescents and young adults. Yacobovich J; Tamary H Acta Haematol; 2014; 132(3-4):340-7. PubMed ID: 25228560 [TBL] [Abstract][Full Text] [Related]
2. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients. Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137 [TBL] [Abstract][Full Text] [Related]
3. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States. Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547 [TBL] [Abstract][Full Text] [Related]
5. Adolescents with sickle cell disease in a rural community: are they ready to transition to adulthood? Mennito S; Hletko P; Ebeling M; Amann LA; Roberts J South Med J; 2014 Sep; 107(9):578-82. PubMed ID: 25188623 [TBL] [Abstract][Full Text] [Related]
6. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians. Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131 [TBL] [Abstract][Full Text] [Related]
7. [Recurrent leg ulcer in a patient with sickle cell-thalassemia disease]. Simonis A; Valkenborgh G; Cauchie C Arch Belg Dermatol; 1974; 30(2):103-6. PubMed ID: 4470370 [No Abstract] [Full Text] [Related]
8. Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Blinder MA; Vekeman F; Sasane M; Trahey A; Paley C; Duh MS Pediatr Blood Cancer; 2013 May; 60(5):828-35. PubMed ID: 23335275 [TBL] [Abstract][Full Text] [Related]
9. Iron metabolism and iron chelation in sickle cell disease. Walter PB; Harmatz P; Vichinsky E Acta Haematol; 2009; 122(2-3):174-83. PubMed ID: 19907155 [TBL] [Abstract][Full Text] [Related]
10. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension. Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292 [TBL] [Abstract][Full Text] [Related]
11. Sickle cell anemia and iron deficiency. Resemblance to sickle thalassemia. Natta C; Weiner MA; Chang H; Wolff JA; Fawaz R JAMA; 1982 Mar; 247(10):1442-3. PubMed ID: 7057533 [No Abstract] [Full Text] [Related]
12. [Treatment of thalassemia and sickle cell anemia in children]. Girot R Ann Pediatr (Paris); 1978; 25(5-6):277-84. PubMed ID: 16114336 [No Abstract] [Full Text] [Related]
13. [Mediastinal adenopathy as a sign of sarcoidosis in a child with sickle cell-thalassemia]. Guillaud R; Grasset A; Marty-Double C; Lesbros D Ann Pediatr (Paris); 1986 Jan; 33(1):67-70. PubMed ID: 3963708 [No Abstract] [Full Text] [Related]
14. Young adults with SCD in US children's hospitals: are they different from adolescents? Dickerson AK; Klima J; Rhodes MM; O'Brien SH Pediatr Blood Cancer; 2012 May; 58(5):741-5. PubMed ID: 21796763 [TBL] [Abstract][Full Text] [Related]
15. What determines severity in sickle-cell disease? Schechter AN; Bunn HF N Engl J Med; 1982 Feb; 306(5):295-7. PubMed ID: 6172711 [No Abstract] [Full Text] [Related]
16. [Anemia and hemoglobin diseases in patients with migration background]. Eber S; Dickerhoff R Dtsch Med Wochenschr; 2014 Feb; 139(9):434-40. PubMed ID: 24557998 [TBL] [Abstract][Full Text] [Related]